Since 2006, LSI has connected medtech companies, investors, and major corporations through expert market intelligence and premium events. Trusted by industry leaders like Medtronic and McKinsey & Co., LSI’s Emerging Medtech Summits foster meaningful partnerships in world-class venues. With data-driven insights and curated events, LSI helps businesses grow and succeed. Work with us. Build breakthroughs.Visit us https://www.lifesciencemarketresearch.com/ Address - 17011 Beach Blvd, Suite 500Huntington Beach, CA 92647Ph no - 7148473540https://www.linkedin.com/company/life-science-intelligence/ https://www.instagram.com/lifescienceintelligence/ https://twitter.com/lsintelligence
Don't wanna be here? Send us removal request.
Text
Neurotechnology: Breaking Barriers to Address Limitations of the Human Body
Brain-computer interfaces (BCIs) are rapidly evolving in medtech, advancing into clinical trials. Synchron, led by CEO Thomas Oxley, pioneers an endovascular BCI, avoiding open brain surgery. Backed by investors like Gates and Bezos, Synchron aims to restore autonomy for paralyzed patients. Inspired by interventional cardiology, Synchron's approach is shaping a new frontier in neurotechnology, merging biomedical innovation with real-world applications.

0 notes
Text
The Memo: Two Frontiers of Innovation—XCath and EndoQuest Robotics
Eduardo Fonseca leads XCath and EndoQuest Robotics, both revolutionizing robotic surgery and endovascular interventions. XCath pioneers remote stroke treatment with intracranial robotics, while EndoQuest develops scar-free flexible surgery. Both spun out from UT’s Microsurgical Robotics Lab and are advancing through pivotal trials. Fonseca will present at LSI USA ‘25, showcasing innovations that could redefine surgical and stroke care worldwide. Join us in Dana Point this March.

0 notes
Text
Make Your Biggest Decisions Data-Driven
Our specialized in-house team has decades of experience evaluating medtech markets and executing custom projects for emerging companies, corporate strategics, consulting and private equity firms, investment banks, and more. Our syndicated market intelligence platform is built by in-house medtech insiders for global medtech executives, with coverage across all medtech markets in all major domestic and global geographies.

0 notes
Text
Your Unfair Advantage to Excel in Medtech
Our in-house team supports enterprise clients on strategy, diligence, and market research so they can win in the evolving Medtech industry. Our specialized in-house team has decades of experience evaluating medtech markets and executing custom projects for emerging companies, corporate strategics, consulting and private equity firms, investment banks, and more.
1 note
·
View note